申请人:Otsuka Pharmaceutical Co., Ltd.
公开号:US05643932A1
公开(公告)日:1997-07-01
A superoxide radical inhibitor containing, as an effective ingredient, an azole derivative represented by the general formula (1), ##STR1## [wherein R.sup.1 represents a phenyl group which may have 1-3 lower alkoxy groups as substituent(s) on the phenyl ring, a phenyl group having a lower alkylenedioxy group, or the like; R.sup.2 represents a hydrogen atom, a phenyl group, a halogen atom, a lower alkoxycarbonyl group, a lower alkyl group, an amino-lower alkyl group which may have a lower alkyl group as a substituent, a dihydrocarbostyril group, or the like; R.sup.3 represents a group of the formula, ##STR2## (R.sup.4B represents a hydroxyl group, a carboxy group, a lower alkenyl group or a lower alkyl group. m represents 0, 1 or 2); X represents a sulfur atom or an oxygen atom] or a salt thereof.
一种含有过氧化物自由基抑制剂的药物,其有效成分为由通式(1)表示的唑类衍生物,其中R.sup.1代表苯基,苯环上可能有1-3个较低的烷氧基取代基,具有较低的烷二氧基基团的苯基,或类似物;R.sup.2代表氢原子,苯基,卤原子,较低的烷氧羰基基团,较低的烷基,可能具有较低烷基取代基的氨基较低烷基基团,二氢碳基苯基,或类似物;R.sup.3代表式的基团,其中(R.sup.4B代表羟基,羧基,较低的烯基基团或较低的烷基。m代表0、1或2);X代表硫原子或氧原子,或其盐。